View Author
patient disease pompe disease fatigue muscle pompe study treatment enzyme replacement therapy van der ploeg alglucosidase alfa group function therapy muscle strength enzyme adult erasmus mc university center children activity alglucosidase chemotherapy strength memory b cells netherland antibody disorder diagnosis level university memory motor value erasmu result marburg range score ploeg lysosomal rotterdam number b cells replacement van doorn pa health reuser effect factor research position table storage symptom titer erasmus mc analysis sumscore month scale fi broblasts polymorphism flammatory bowel disease marburg i polymorphism van der beek stroke motor function test department lesion muscle weakness reference values weakness response infusion reference muscle groups ficiency compartment syndrome
10 Most Recent Publications
|
Enzyme replacement therapy and fatigue in adults with Pompe disease
(Article)
Güngör, D. Vries, J.M. de Plug, I. Ploeg, A.T. van der Brusse, E. Kruijshaar, M.E. Hop, W.C.J. Murawska, M. Berg, L.E.M. van den Reuser, A.J.J. Doorn, P.A. van Hagemans, M. |
2013-04-19
|
|
Severely impaired health status at diagnosis of Pompe disease: A cross-sectional analysis to explore the potential utility of neonatal screening
(Article)
Rigter, T. Weinreich, S.S. El, C.G. van Vries, J.M. de Gelder, C.M. van Güngör, D. Reuser, A.J.J. Hagemans, M. Cornel, M.C. Ploeg, A.T. van der |
2012-11-01
|
|
Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: An open-label single-center study
(Article)
Vries, J.M. de Beek, N.A.M.E. van der Faber, C.G. Verschuuren, J.J. Kruijshaar, M.E. Reuser, A.J.J. Doorn, P.A. van Ploeg, A.T. van der Hop, W.C.J. Karstens, F.P. Wokke, J.H.J. Visser, M. de Engelen, B.G. van Kuks, J.B.M. Kooi, A.J. van der Notermans, N.C. |
2012-09-28
|
|
First experience with enzyme replacement therapy during pregnancy and lactation in Pompe disease
(Article)
Vries, J.M. de Brugma, J.D.C. Özkan, L. Steegers, E.A.P. Reuser, A.J.J. Doorn, P.A. van Ploeg, A.T. van der |
2011-12-01
|
|
The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients
(Article)
Capelle, C.I. van Beek, N.A.M.E. van der Vries, J.M. de Doorn, P.A. van Duivenvoorden, H.J. Leshner, R.T. Hagemans, M.L.C. Ploeg, A.T. van der |
2011-09-13
|
|
Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy
(Article)
Güngör, D. Vries, J.M. de Hop, W.C.J. Reuser, A.J.J. Doorn, P.A. van Ploeg, A.T. van der Hagemans, M.L.C. |
2011-06-03
|
|
A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers
(Article)
Berg, L.E.M. van den Vries, J.M. de Verdijk, R.M. Ploeg, A.T. van der Reuser, A.J.J. Doorn, P.A. van |
2011-03-01
|
|
High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa
(Article)
Vries, J.M. de Beek, N.A.M.E. van der Kroos, M.A. Özkan, L. Doorn, P.A. van Richards, S.M. |
2010-12-01
|
|
Low bone mass in Pompe disease. Muscular strength as a predictor of bone mineral density
(Article)
Berg, L.E.M. van den Zandbergen, A.A.M. Capelle, C.I. van Vries, J.M. de Hop, W.C.J. Hout, J.M.P. van den Reuser, A.J.J. Zillikens, M.C. Ploeg, A.T. van der |
2010-09-01
|
|
Fatigue in neuromuscular disorders: Focus on Guillain-Barré syndrome and Pompe disease
(Article)
Vries, J.M. de Hagemans, M.L.C. Bussmann, J.B.J. Ploeg, A.T. van der Doorn, P.A. van |
2010-03-01
|
